TV

Five things for pharma marketers to know: Tuesday, August 29, 2017

Five things for pharma marketers to know: Tuesday, August 29, 2017

By

Drug ads make up to 38% of prime time commercials; Merck considers whether to pursue FDA approval for anacetrapib; BMS and Daiichi partner

Truth Initiative asks whether Big Tobacco is exploiting veterans and the mentally ill

Truth Initiative asks whether Big Tobacco is exploiting veterans and the mentally ill

By

News-style segments for MTV's Video Music Awards expose how brands have marketed cigarettes to already vulnerable groups.

Five things for pharma marketers to know: Friday, April 14, 2017

Five things for pharma marketers to know: Friday, April 14, 2017

By

Lawmaker wants better enforcement of TV ads placed by lawyers; more toddlers are taking antipsychotics; Neurocrine puts off price disclosure of new drug

Five things for pharma marketers to know: Wednesday, April 5, 2017

Five things for pharma marketers to know: Wednesday, April 5, 2017

By

GSK pulls ads from "The O'Reilly Factor"; the FDA approves drug for Huntington's disease patients; lawmakers may remove pre-existing conditions requirement

The 2017 DTC Report: All the data in one place

The 2017 DTC Report: All the data in one place

Drugmakers again spent more on DTC advertising in 2016 than the year before.